DocGo Inc.
Close on Oct 19, 2026
- Market cap
- $25.18M
- P/E (TTM)
- –
- Dividend yield
- –
About DocGo
Services-Health Services, SIC 8000
DocGo Inc. provides mobile healthcare and medical transportation solutions outside traditional clinical settings. The company conducts business through three segments: Mobile Health Services, Transportation Services, and Corporate. Its Mobile Health Services segment delivers on-site evaluation, diagnostics, triage, chronic condition monitoring, and gap closure services to patients in residences, workplaces, and community environments. Under the Ambulnz brand, the Transportation Services segment operates digitally enabled medical transport and ambulance transfers integrated with hospital record systems. DocGo serves diverse customers, including municipalities, hospital systems, health insurance providers, employers, physician practices, and government entities.
DocGo operates across all 50 U.S. states and within the United Kingdom. Its medical fleet comprises 582 vehicles deployed in the United States and 288 vehicles serving the United Kingdom. The organization employs nearly 3,600 personnel, including field healthcare clinicians, management staff, and corporate personnel, supplemented by over 800 subcontracted workers and independent contractors. The provided text does not mention the location of the company's corporate headquarters.
Summary of the business section of DocGo's latest annual report, written by StockData.
Company profile
Company
- Legal name
- DocGo Inc.
- Founded
- 2015
- Headquarters
- New York, NY
- Address
- 685 Third Avenue, 9th Floor 10017
- Phone
- (844) 443-6246
- Employees
- 3,600, Dec 31, 2025
- Industry
- Services-Health Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Urish Popeck & Co., LLC, Pittsburgh, PA
Stock & identifiers
- Ticker
- DCGO
- Exchange
- Nasdaq
- IPO date
- Oct 16, 2020
- Shares outstanding
- 99M, Aug 14, 2026
- Public float
- $149.56M, Jun 30, 2025
- Filer category
- Accelerated filer<br>Smaller reporting company
- SEC CIK
- 1822359
- CUSIP
- 256086109
- ISIN
- US2560861096
- EIN
- 85-2515483
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Lee Bienstock | Chief Executive Officer, Director | 2,801,826 |
| Ely D. Tendler | General Counsel and Secretary, Director | 258,795 |
| Norman Rosenberg | CFO and Treasurer | 1,223,571 |
| Stephen Sugrue | Chief Compliance Officer | 636,602 |
| Etalvina Leite | Director | 201,411 |
| Michael J. Burdiek | Director | 3,364,773 |
| James M. Travers | Director | 3,507,027 |
| Ira Smedra | Director | 240,999 |
| Stephen K. M.D. Klasko | Director | 115,000 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Lee Bienstock | $3.57M | -$1.14M | $1.51M | $12 | – |
| FY2024 Lee Bienstock | $7.56M | $4.01M | $2.66M | $60 | – |
| FY2024 Mr Bienstock | $7.56M | $4.01M | $2.66M | $60 | – |
| FY2023 Anthony Capone | $928.90K | -$1.20M | $3.13M | $79 | – |
| FY2023 Lee Bienstock | $11.35M | $10.91M | $3.13M | $79 | – |
| FY2023 Mr Bienstock | $11.35M | $10.91M | $3.13M | $79 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had nearly 3,600 employees, including healthcare professionals, field management personnel and corporate support staff, as represented in the table below.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 10, 2026 | Late filing | Notification of late filing |
| Jul 31, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jan 30, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Sep 16, 2022 | Delisting | Notice of delisting from exchange (Form 25) |
| Nov 12, 2021 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Nov 12, 2021 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Nov 5, 2021 | Delisting | Notice of delisting from exchange (Form 25) |
| Nov 5, 2021 | Name change | Name changed from Motion Acquisition Corp. to DocGo Inc. |
| Jul 2, 2021 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| May 28, 2021 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| May 13, 2021 | Late filing | Notification of late filing |
| Oct 16, 2020 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 14, 2020 | Listing | Registration of securities on an exchange (Form 8-A) |